VNA-318
Asset
Brain-penetrant mitophagy inducer that restores mitochondrial function and reduces inflammation.
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Autophagy
- 3
- Indications
- 0
- Trials
- 1
- Developer
Indications
3Alzheimer's disease
Phase 1, vandria.com, 10 Oct 2026
Major depressive disorder
Phase 1, vandria.com, 10 Oct 2026
Neurodegenerative disease
Phase 1, vandria.com, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors12
- Aging relevance2
Every asset’s record: target, stage, trials and the evidence behind it.